Excitatory/inhibitory neuronal metabolic balance in mouse hippocampus upon infusion of [U-13C6]glucose

被引:5
|
作者
Cherix, Antoine [1 ]
Donati, Guillaume [1 ]
Lizarbe, Blanca [1 ,2 ]
Lanz, Bernard [1 ,3 ]
Poitry-Yamate, Carole [1 ]
Lei, Hongxia [4 ]
Gruetter, Rolf [1 ]
机构
[1] Ecole Polytech Fed Lausanne, Lab Funct & Metab Imaging, Lausanne, Switzerland
[2] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain
[3] Univ Nottingham, Sch Med, SPMIC, Nottingham, England
[4] Ecole Polytech Fed Lausanne, Ctr Biomed Imaging CIBM AIT, CH FI 627 Batiment CH,Stn 6, CH-1015 Lausanne, Switzerland
来源
基金
瑞士国家科学基金会;
关键词
H-1-[C-13]-MRS; neuronal metabolism; metabolic modeling; TCA cycle; mouse hippocampus; C-13; NMR-SPECTROSCOPY; BRAIN IN-VIVO; GABA-TRANSAMINASE INHIBITION; NUCLEAR-MAGNETIC-RESONANCE; RAT-BRAIN; GLUCOSE-METABOLISM; ENERGY-METABOLISM; GLIAL METABOLISM; CORTICAL GABA; TCA CYCLE;
D O I
10.1177/0271678X20910535
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hippocampus plays a critical role in linking brain energetics and behavior typically associated to stress exposure. In this study, we aimed to simultaneously assess excitatory and inhibitory neuronal metabolism in mouse hippocampus in vivo by applying (18)FDG-PET and indirect C-13 magnetic resonance spectroscopy (H-1-[C-13]-MRS) at 14.1 T upon infusion of uniformly C-13-labeled glucose ([U-C-13(6)]Glc). Improving the spectral fitting by taking into account variable decoupling efficiencies of [U-C-13(6)]Glc and refining the compartmentalized model by including two gamma-aminobutyric acid (GABA) pools permit us to evaluate the relative contributions of glutamatergic and GABAergic metabolism to total hippocampal neuroenergetics. We report that GABAergic activity accounts for similar to 13% of total neurotransmission (V-NT) and similar to 27% of total neuronal TCA cycle (V-TCA) in mouse hippocampus suggesting a higher V-TCA/V-NT ratio for inhibitory neurons compared to excitatory neurons. Finally, our results provide new strategies and tools for bringing forward the developments and applications of C-13-MRS in specific brain regions of small animals.
引用
收藏
页码:282 / 297
页数:16
相关论文
共 21 条
  • [1] Limitations in the use of [U-13C6]glucose to estimate gluconeogenesis
    Landau, BR
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (03): : E408 - E413
  • [2] Metabolic Reprogramming of Senescent Lung Epithelial Cells: U-13C6 Glucose Fluxomics Study
    Shaghaghi, H.
    Ojeda-Lassalle, Y.
    Tarn, C.
    Romero, F.
    Rara, R.
    Capreri, D.
    Summer, R. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [3] Underestimation of gluconeogenesis by the [U-13C6]glucose method:: effect of lack of isotope equilibrium
    Mao, CS
    Bassilian, S
    Lim, SK
    Lee, WNP
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 282 (02): : E376 - E385
  • [4] BIOSYNTHETIC INCORPORATION OF GLUCOSE [U-13C6] INTO THE C7N2 UNIT OF ANTIBIOTIC A23187
    ZMIJEWSKI, MJ
    TETRAHEDRON LETTERS, 1982, 23 (17) : 1775 - 1776
  • [5] Regulation of gluconeogenesis measured using 2H2O and [U-13C6] glucose
    Staehr, P
    Hother-Nielsen, O
    Beck-Nielsen, H
    Chandramouli, V
    Previs, SF
    Landau, BR
    DIABETOLOGIA, 2002, 45 : A187 - A187
  • [6] THE BIOSYNTHESIS OF STREPTONGRIN - BIOSYNTHESIS OF STREPTONIGRIN FROM [U-13C6]-D-GLUCOSE - ORIGIN OF THE QUINOLINE QUINONE
    GOULD, SJ
    CANE, DE
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1982, 104 (01) : 343 - 346
  • [7] Limitations in estimating gluconeogenesis and Cori cycling from mass isotopomer distributions using [U-13C6]glucose
    Landau, BR
    Wahren, J
    Ekberg, K
    Previs, SF
    Yang, DW
    Brunengraber, H
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 274 (05): : E954 - E961
  • [8] Hydrocortisone administration increases glucose production and gluconeogenesis in normal volunteers measured by [U-13C6]glucose and mass isotopomer analysis.
    Tayek, JA
    FASEB JOURNAL, 1999, 13 (05): : A877 - A877
  • [10] IN VIVO AND IN VITRO MECHANISM OF ACTION OF INHIBITORS OF DE NOVO LIPOGENESIS PATHWAY LEVERAGING [U-13C6]-GLUCOSE LC/MS
    Qi, Jenson
    Lang, Wensheng
    Wang, Sheng-Ping
    Liu, JianYing
    Meng, Rong
    Guo, Lili
    Krosky, Daniel
    Barbay, Kent
    Nawrocki, Andrea
    Pocai, Alessandro
    Lee, Seunghun Paul
    HEPATOLOGY, 2020, 72 : 335A - 335A